Xtandi vs Ocrevus
Side-by-side drug price comparison from Medicare Part D data
Verdict
Xtandi costs 61% less per claim than Ocrevus ($9331.00 vs $23635.00). Xtandi has a generic alternative available. Total Medicare spending: Xtandi at $4.1B vs Ocrevus at $3.5B.
| Metric | Xtandi | Ocrevus |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $9,331* | $23,635 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $4.1B | $3.5B |
| Total Claims | 438,000 | 148,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 9.4%* | 16.5% |
| Generic Available | Yes | Yes |
| Condition | Cancer | Multiple Sclerosis |
| Total Beneficiaries | 46,000 | 62,000 |
Xtandi costs 61% less per claim than Ocrevus ($9331.00 vs $23635.00). Xtandi has a generic alternative available. Total Medicare spending: Xtandi at $4.1B vs Ocrevus at $3.5B.